dr. rogers on benefits of ibrutinib combination in cll
Published 6 years ago • 209 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:25
dr. rogers discusses obinutuzumab, ibrutinib, and venetoclax combination in cll
-
2:42
dr. rogers discusses early intervention with ibrutinib in cll
-
1:19
dr. rogers discusses data for ibrutinib in hairy cell leukemia
-
1:02
dr. gerson on venetoclax/obinutuzumab combination in cll
-
0:41
dr. chavez on combination of ibrutinib plus ublituximab in cll
-
0:57
dr. byrd on alacabrutinib's mechanism of action in cll
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
1:44
dr. mato on ibrutinib-based combinations in cll
-
2:12
dr. brander on the safety and efficacy of ibrutinib/venetoclax in cll
-
9:02
efficacy and future role of ibrutinib in cll and mcl
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
5:50
idelalisib in chronic lymphocytic leukemia
-
0:53
dr. kambhampati on frontline ibrutinib plus obinutuzumab in cll
-
1:35
dr. awan discusses combinations with ibrutinib in cll
-
1:29
dr. byrd on ibrutinib's impact on treatment landscape in cll
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
1:39
dr. woyach on the role of acalabrutinib in cll
-
2:02
dr. kahl on promising research in chronic lymphocytic leukemia